rs117146868 (SMOC1): AMD and blood lipoproteins

Key takeaways

• rs117146868 falls near SMOC1, a gene examined in research on age-related macular degeneration (AMD), the leading cause of irreversible central vision loss in adults over 50.
• A study of 72,376 UK Biobank participants found 84 blood metabolites significantly associated with AMD, with lipoprotein subclasses accounting for 39% of those markers.
• Depletion of very small very low-density lipoprotein (VLDL) particles in circulation was identified as likely causally linked to AMD, not merely correlated.
• Age remains the dominant predictor of AMD risk; metabolites contribute a smaller but detectable role in risk prediction models.

What the research says A three-tiered analysis of 325 blood metabolites in 72,376 UK Biobank donors (1,353 AMD cases and 71,023 controls) identified 84 metabolic markers significantly associated with AMD after accounting for age and sex, with a false discovery rate-adjusted P < 0.05 threshold. Lipoprotein subclasses comprised 39% of those AMD-associated metabolites. A two-sample Mendelian randomization analysis - a statistical method that uses genetic variants as proxies to test whether an exposure causally affects an outcome, reducing confounding from lifestyle or reverse causation - identified 19 metabolites with likely causal roles in AMD etiology, including 6 lipoprotein markers containing very small VLDL particles and phospholipid-to-total-lipid ratio in medium VLDL, leading the authors to postulate that depletion of circulating very small VLDL is likely causal for AMD.

Reported associations

• Age-related macular degeneration - very small VLDL depletion: Low circulating levels of very small VLDL particles were identified as likely causally linked to AMD via Mendelian randomization in 72,376 UK Biobank participants.
• AMD - lipoprotein subclasses broadly: Lipoprotein subclasses accounted for 39% of the 84 blood metabolites significantly associated with AMD (FDR-adjusted P < 0.05), the largest single category.
• AMD - phospholipid ratios: Phospholipid-to-total-lipid ratio in medium VLDL was among the 19 metabolites identified as likely causally involved in AMD development.
• AMD - metabolite-based risk prediction: A machine learning classifier using metabolites, age, and sex found age to be the primary predictive factor for AMD, with metabolites adding a smaller incremental contribution.

Evidence quality The source study draws on 72,376 UK Biobank donors with 1,353 AMD cases, providing substantial statistical power, and applies a Mendelian randomization design that is more robust to confounding than simple observational association. Significance was assessed using false discovery rate adjustment rather than a nominal P-value threshold, reducing the rate of false positives across 325 metabolite tests. However, the study describes its causal conclusions as "likely causal" rather than definitive, and no replication cohort is described in the available text. Specific effect sizes or association statistics for rs117146868 individually were not reported in the available study. The risk prediction modeling finding - that age dominates and metabolites contribute incrementally - suggests that metabolite-level signals, including any variant-mediated effects on lipoprotein levels, should be interpreted in a multifactorial context rather than in isolation.

Lifestyle considerations No lifestyle considerations on file for this variant.